Immuno-oncology. Biologics. Cell and gene therapies. This is the future of medicine. It’s more personalized, more complex and driving an increase in demand for highly technical nonclinical studies that require study models that most closely resemble the human body. Oftentimes, it’s nascent science that demands a new study that hasn’t even been invented yet.
Labcorp Plasma Detect is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer BURLINGTON, N.C. , April 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of
April is National Stress Awareness Month and a great time to take stock on common stressors in life. It may seem counterintuitive, but some stress is actually good. It motivates us to get things done and can be used as an opportunity to grow, change direction or start over.Unfortunately, the volume and impact of negative stress are extensive—and costly.
Watch subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes.
Hear from multiple myeloma subject matter experts Joseph Michael, MD, Med, FRCPC, FACP, and Saad Usmani, MD, MBA, FACP, FASCO, on early detection and referral to hematology for improved patient outcomes.
Researchers to present on topics ranging from molecular residual disease and immunotherapy to whole-genome sequencing BURLINGTON, N.C. , April 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will present abstracts in the areas of
